DC Chemicals

All products / DC7944

LY2090314
CAT. NO. DC7944

LY2090314

Pack sizes and prices

Pack sizePrice
100 mg$750 USDRequest a quote →
250 mg$1,300 USDRequest a quote →
1 g$2,600 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

LY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC7944
Product nameLY2090314
CAS603288-22-8
Molecular formulaC28N6O3FH25
Molecular weight512.5349
Purity>98%
SMILESFC1C([H])=C2C(C3C(N([H])C(C=3C3=C([H])N=C4C([H])=C([H])C([H])=C([H])N34)=O)=O)=C([H])N3C([H])([H])C([H])([H])N(C(N4C([H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])=O)C([H])([H])C(C=1[H])=C32

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — LY2090314 (DC7944)

Source references

[1]. Zamek-Gliszczynski MJ, et al. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure. Dr [2]. Atkinson JM, et al. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3. PLoS One. 2015 Apr 27;10(4):e0125028.

Related research products